Success Story: NIW Approved In Record Time With Premium Processing! Our Firm Helped a Chinese Scientist Advance Reproductive Medicine Innovation
Client’s Testimonial:
"Thanks for your confirmation. I feel relieved. It's a great experience to work with you.”
On April 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Reproductive Medicine (Approval Notice).
General Field: Reproductive Medicine
Position at the Time of Case Filing: Scientist
Country of Origin: China
State of Residence at the Time of Filing: Colorado
Approval Notice Date: April 6th, 2026
Processing Time: 1 month, 4 days (Premium Processing Requested)
Case Summary:
With a Ph.D. in reproductive physiology, the client secured I-140 NIW approval in 35 days through direct Premium Processing. His case centered on a proposed endeavor in reproductive medicine: continuing research that integrates basic and translational work in reproductive and stem cell biology to advance assisted reproductive technologies and improve the success, accessibility, and affordability of treatment for patients. At the time of filing, the client was already working as a scientist in the field, which helped show that his plans were not speculative but a continuation of ongoing, specialized work.
What made this case persuasive was the way the evidence tied the client’s record to real national needs. His work addressed problems directly relevant to fertility treatment outcomes, including embryo culture conditions, oocyte activation, and early embryo development. In the petition, we emphasized that improving ART is not only a scientific goal but also a healthcare priority, especially as more patients rely on these treatments while still facing meaningful risks, costs, and inconsistent outcomes. The filing also highlighted that his research had attracted major support from the National Institutes of Health and the Department of Agriculture, an important sign that knowledgeable U.S. agencies had already recognized the broader value of this work.
The client’s scholarly record further strengthened the case. He had authored 10 peer-reviewed journal articles and 6 conference abstracts, with significant first-authored contributions, and his work had been cited 61 times. He had also completed at least 40 reviews and served in an editorial role, which was important because adjudicators often view peer review activity as evidence that the field trusts a researcher’s judgment. The petition did not treat these numbers as self-proving. Instead, it explained that several of his papers were cited at rates above field averages for their publication years, showing meaningful reliance by other researchers rather than routine publication alone.
The filing also included 1 recommendation letter supporting the significance of the client’s work and his ability to continue advancing it in the United States. The expert noted:
“Ensuring that [Client’s] work proceeds is thus not only important to the field, but to the United States as well.”
We are proud that our firm had the opportunity to assist this client in securing NIW approval.